Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

LillyDirect Foundayo vs Strut Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

8.5

LillyDirect Foundayo

Best for patients with commercial insurance who want the cheapest legal brand-name GLP-1
★★★★4.3

Starting at $25/mo

Manufacturer DirectFoundayoBrand NameLilly Savings Card
Visit LillyDirect Foundayo
8.1

Strut Health

Best for oral-lozenge compounded GLP-1 access
★★★★4.1

Starting at $99/mo

CompoundedSemaglutideTirzepatideOral Lozenge Option
Visit Strut Health

Side-by-Side Comparison

FeatureLillyDirect FoundayoStrut Health
Overall Score8.5/108.1/10
Starting Price$25/mo$99/mo
Editorial Rating4.3 ★ /54.1 ★ /5
Features5 features6 features
States Available5149
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

LillyDirect Foundayo

Pros

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Cons

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

Strut Health

Pros

  • Both LegitScript and ACHC accreditation — pharmacy oversight standard most compounded GLP-1 providers don't advertise
  • Oral lozenge formulation available for semaglutide ($99/mo) and tirzepatide ($199/mo) — injection-free alternative
  • Transparent auto-refill pricing with 13–21% savings vs. one-off orders
  • Free unlimited follow-up messaging with board-certified US physicians
  • 49 states covered (only Arkansas excluded as of September 2024)

Cons

  • 'Medical necessity' eligibility gate — Strut's prescribers evaluate whether treatment is medically appropriate but the criteria are not publicly defined, so users can't self-screen before paying for a consultation
  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro option
  • Pharmacy partners not publicly named — users can't independently verify 503A/503B compounding source
  • No insurance accepted — cash pay only
  • Phone consultation requirement varies by state (not every state mandates a synchronous visit)

Our Verdict

Winner: LillyDirect FoundayoScore: 8.5/10

LillyDirect Foundayo edges out Strut Health with a higher overall score of 8.5/10 and is particularly strong for patients with commercial insurance who want the cheapest legal brand-name GLP-1. Strut Health remains a solid alternative, especially if you're looking for oral-lozenge compounded GLP-1 access.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.